GIGAA LASER provide high quality and affordable diode laser for various animal treatment.
donna@gigaalaser.com
2016年1月24日星期日
2016年1月18日星期一
Gigaa Laser gets FDA approval K151890 for surgical lasers
GBOX-15A/15B, VELASII-30A/30B and VELASII-60A/60B/60C are approved by FDA for use in surgical applications requring the hemostasis, ablation, vaporization, excision,incision and coagulation of soft tissues. For more information, please check K151890 in FDA system.
External and intralesional photocoagulation of hemangioma in children with infrared diode laser
Infra-red diode laser with wavelength 1060 nm was used for combined treatment of 163 children aged from 21 days to 13 years with 221 hemangiomas. For interstitial coagulation a power of 1.8-2 W and a power density of 5-90 J/cm3 were used in continuous mode. For distant coagulation pulse mode was applied with pulse/pause duration 30-50/200-250 ms, average power 1.3-2 W, and power density 65-450 J/cm2. 197 (89.1 %) hemangiomas were capillary, 7 (3.2 %) cavernous, and 17 (7.7 %) combined (combination of capillary and cavernous hemangiomas). The area of hemangiomas ranged from 6 mm2 to 48 cm2. For the majority (193, 87.3 %) of hemangiomas one session of photocoagulation was enough to achieve a good cosmetic effect. However, 28 (12.7 %) hemangiomas were treated repeatedly, 11 (5%) of them needed 4-7 sessions. In 8 children with cavernous and combined hemangiomas both distant and interstitial laser coagulation were used. In all, good or excellent results were obtained in 96,3 % of the patients. In 6 (3.7%) patients with extensive combined hematomas the considerable improvement was achieved.
2016年1月11日星期一
Meet GIGAA LASER at Arab Health at HALL 8, 8E51
Arab Health 2016 will be held in Dubai International Convention & Exhibition Centre, we are looking forward to meet you during Arab Health 2016, please visit our booth at HALL 8, 8E51
donna@gigaalaser.com
2016年1月3日星期日
订阅：
博文 (Atom)